approved

Приложение 4 на ПЛС от 02.02.2020 г.

Unique identificator:  e32ee62a-20f3-4b49-bfff-c3c71123e114

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-02-03 12:46:35
  • Created by: georgi_sivchev
  • Updated at: 2020-02-03 12:46:35
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Electrolytes 20010534 Ringer Lactate Baxter (пластмасови сакове и стъклени бутилки), Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 500 ml, ml, Pack: 20 Бакстер България ЕООД, България Bieffe Medital S.A., Spain; Bieffe Medital S.p.A., Italy; Baxter Healthcare Ltd., Caxton Way, Thretford, Norfolk IP24 3SE, Обединено кралство; Baxter S.A, Boulevard Rene Branquart 80, 7860 Lessines, Белгия 30.78 6.16 36.94 4% 1.23 32.01 6.4 38.41 16% 4.92 36.93 7.39 44.32 промяна в обстоятелства НСР-5053/18.11.2014 КЦРР-1889/15.12.2012 г 02.01.2013 02.01.2013 Неактивен 1529
Electrolytes ІІ-13012/17.05.2006 г. RINGER LACTATE SOLUTION, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 500 ml, ml, Pack: 1 Fresenius Kabi Deutschland GmbH, Германия Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43 I-37063 Isola Della Scala-Verona, Italy 1.66 0.33 1.99 7% 0.12 1.78 0.36 2.14 20% 0.33 2.11 0.42 2.53 КЦ-929/28.05.2009; НСР-12066/21.03.2017 11.06.2009 02.05.2017 Заличен 752
Electrolytes ІІ-13012/17.05.2006 г. RINGER LACTATE SOLUTION, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 500 ml, ml, Pack: 1 Fresenius Kabi Deutschland GmbH, Германия Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43 I-37063 Isola Della Scala-Verona, Italy 1.66 0.33 1.99 7% 0.12 1.78 0.36 2.14 20% 0.33 2.11 0.42 2.53 КЦ-929/28.05.2009 11.06.2009 11.06.2009 Неактивен 752
Electrolytes 20030104 Ringer Lactatе Baxter, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 1000 ml, ml, Pack: 10 Бакстер България ЕООД, България Bieffe Medital S.A., Spain; Bieffe Medital S.p.A., Italy; Baxter Healthcare Ltd., Caxton Way, Thretford, Norfolk IP24 3SE, Обединено кралство; Baxter S.A, Boulevard Rene Branquart 80, 7860 Lessines, Белгия 19.75 3.95 23.7 6% 1.19 20.94 4.19 25.13 18% 3.56 24.5 4.9 29.4 НСР-5950/01.04.2015. 16.04.2015 16.04.2015 Неактивен 3784
Electrolytes 20030104 Ringer Lactatе Baxter, Solution for infusion, Sodium Chloride 6 g/l, Sodium Lactate solution 50 % 6.34 g/l Potassium Chloride 0.4 g/l, Calcium Chloride dihydrate 0.27 g/l - 1000 ml, ml, Pack: 10 Бакстер България ЕООД, България Bieffe Medital S.A., Spain; Bieffe Medital S.p.A., Italy; Baxter Healthcare Ltd., Caxton Way, Thretford, Norfolk IP24 3SE, Обединено кралство; Baxter S.A, Boulevard Rene Branquart 80, 7860 Lessines, Белгия 21.81 4.36 26.17 6% 1.31 23.12 4.62 27.74 18% 3.93 27.05 5.41 32.46 промяна в обстоятелства НСР-5054/18.11.2014 КЦРР-1889/15.12.2012 г 02.01.2013 02.01.2013 Неактивен 3784
Electrolytes II-13809/ 11.07.2006 Ringer`s injection Bieffe, Solution for infusion, 0.33 g/ 0.3 g/ 8.6 g/l - 250 ml, ml, Pack: 30 Baxter d.o.o., Словения Bieffe Medital S.p.A. 39.59 7.92 47.51 4% 1.58 41.17 8.23 49.4 16% 6.33 47.5 9.5 57 КЦ-950/10.06.2009; НСР-12068/21.03.2017 30.06.2009 02.05.2017 Заличен 755
Electrolytes II-13809/ 11.07.2006 Ringer`s injection Bieffe, Solution for infusion, 0.33 g/ 0.3 g/ 8.6 g/l - 250 ml, ml, Pack: 30 Baxter d.o.o., Словения Bieffe Medital S.p.A. 39.59 7.92 47.51 4% 1.58 41.17 8.23 49.4 16% 6.33 47.5 9.5 57 КЦ-950/10.06.2009 30.06.2009 30.06.2009 Неактивен 755
Electrolytes ІІ-13649/22.06.2006 г. Ringer solution, Solution for infusion, 500, ml, Pack: 1 Fresenius Kabi Deutschland GmbH, Германия Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43, I-37063 Isola Della Scala-Verona, Italy 1.66 0.33 1.99 7% 0.12 1.78 0.36 2.14 20% 0.33 2.11 0.42 2.53 КЦ-929/28.05.2009; НСР-12067/21.03.2017 11.06.2009 02.05.2017 Заличен 753
Electrolytes ІІ-13649/22.06.2006 г. Ringer solution, Solution for infusion, 500, ml, Pack: 1 Fresenius Kabi Deutschland GmbH, Германия Fresenius Kabi Austria GmbH, Hafnerstrasse 36 A-8055 Graz, Austria; Fresenius Kabi Deutschland GmbH, D-61346 Bad Homburg v.d.H., Germany; Fresenius Kabi Italia SpA, Via Camagre, 41-43, I-37063 Isola Della Scala-Verona, Italy 1.66 0.33 1.99 7% 0.12 1.78 0.36 2.14 20% 0.33 2.11 0.42 2.53 КЦ-929/28.05.2009 11.06.2009 11.06.2009 Неактивен 753
Pioglitazone 20110728 Riodin, Tablet, 45, mg, Pack: 30 Stada Arzneimittel AG, Германия Hemopharm GmbH, Konigsteiner Strabe 2, 61350 Bad Homburg, Германия 54.57 10.91 65.48 4% 2.18 56.75 11.35 68.1 16% 8.73 65.48 13.1 78.58 цената се заличава с решение НСР-6861/30.07.2015 (в сила от 02.09.2015 г) НСР-1628/01.11.2013 19.11.2013 19.11.2013 Заличен 2211
Pioglitazone 20110727 Riodin, Tablet, 30, mg, Pack: 30 Stada Arzneimittel AG, Германия Hemopharm GmbH, Konigsteiner Strabe 2, 61350 Bad Homburg, Германия 40.39 8.08 48.47 4% 1.62 42.01 8.4 50.41 16% 6.46 48.47 9.69 58.16 цената се заличава с решение НСР-6860/30.07.2015 (в сила от 02.09.2015 г) НСР-1628/01.11.2013 19.11.2013 19.11.2013 Заличен 2210
Pioglitazone 20110726 Riodin, Tablet, 15, mg, Pack: 30 Stada Arzneimittel AG, Германия Hemopharm GmbH, Konigsteiner Strabe 2, 61350 Bad Homburg, Германия 26.4 5.28 31.68 6% 1.58 27.98 5.6 33.58 18% 4.75 32.73 6.55 39.28 цената се заличава с решение НСР-6859/30.07.2015 (в сила от 02.09.2015 г) НСР-1628/01.11.2013 19.11.2013 19.11.2013 Заличен 2209
Risperidone 20180303 Risdone, Oral solution, 1 mg/ml - 100 ml, -, Pack: 1 Неола Фарма ЕООД, България Медитрайл Интернешънълс ЕООД, България 17.27 3.45 20.72 6% 1.04 18.31 3.66 21.97 18% 3.11 21.42 4.28 25.7 НСР-19566/21.08.2019 05.09.2019 02.10.2019 Активен 16670
Risperidone 20180303 Risdone, Oral solution, 1 mg/ml - 100 ml, -, Pack: 1 Неола Фарма ЕООД, България Медитрайл Интернешънълс ЕООД, България 17.27 3.45 20.72 6% 1.04 18.31 3.66 21.97 18% 3.11 21.42 4.28 25.7 НСР-19566/21.08.2019 05.09.2019 02.10.2019 Неактивен 16670
Risedronate № II 9782/04.06.2010 Risendros 35 mg, Film coated tablet, 35, mg, Pack: 4 Zentiva k.s., Чешка република Zentiva k.s. - Чешка република 4.26 0.85 5.11 7% 0.3 4.56 0.91 5.47 20% 0.85 5.41 1.08 6.49 цената е заличена с Решение НСР-5555/29.01.2015 (в сила от 16.02.2015 ) КЦРР-2216/06.02.2013 14.03.2013 14.03.2013 Заличен 1199
Risedronate № II 9782/04.06.2010 Risendros 35 mg, Film coated tablet, 35, mg, Pack: 4 Zentiva k.s., Чешка република Zentiva k.s.U Kabelovny 130, Dolni Mecholupy 102 37 Pradue 10, Чешка република Zentiva a.s. Nitrinska 100 920 27 Hlohovec, Словакия 13.1 2.62 15.72 6% 0.79 13.89 2.78 16.67 18% 2.36 16.25 3.25 19.5 издадена корекционна КЦ-2239/20.05.2011 КЦ-2175/21.04.2011 10.05.2011 10.05.2011 Неактивен 1199
Risperidone II-1937/16,04,2008 RISPOLEPT CONSTA 25 MG, Powder and solvent for prolonged release suspension for injection, 25, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 170.22 34.04 204.26 4% 6.81 177.03 35.41 212.44 16% 25 202.03 40.41 242.44 цената се заличава КЦРР-1361/05.09.2012 КЦ-380/07.01.2009 27.01.2009 27.01.2009 Заличен 406
Risperidone II-1935/16.04.2008 RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 187.56 37.51 225.07 4% 7.5 195.06 39.01 234.07 16% 25 220.06 44.01 264.07 НСР-8046/12.02.2016.; НСР-13238/17.07.2017 27.02.2016 02.11.2017 Заличен 3342
Risperidone II-1935/16.04.2008 RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 187.56 37.51 225.07 4% 7.5 195.06 39.01 234.07 16% 25 220.06 44.01 264.07 НСР-8046/12.02.2016. 27.02.2016 27.02.2016 Неактивен 3342
Risperidone II-1935/16.04.2008 RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 187.62 37.52 225.14 4% 7.5 195.12 39.02 234.14 16% 25 220.12 44.02 264.14 НСР-5004/05.11.2014 19.11.2014 19.11.2014 Неактивен 3342
Risperidone II-1935/16.04.2008 RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 195.66 39.13 234.79 4% 7.83 203.49 40.7 244.19 16% 25 228.49 45.7 274.19 НСР-2424/21.01.2014 20.03.2014 20.03.2014 Неактивен 3342
Risperidone II-1935/16.04.2008 RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 200.49 40.1 240.59 4% 8.02 208.51 41.7 250.21 16% 25 233.51 46.7 280.21 КЦРР-2804/20.03.2013 21.05.2013 21.05.2013 Неактивен 3342
Risperidone II-1935/16,04,2008 RISPOLEPT CONSTA 37,5 MG, Powder and solvent for prolonged release suspension for injection, 37.5, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 221.28 44.26 265.54 4% 8.85 230.13 46.03 276.16 16% 25 255.13 51.03 306.16 КЦ-380/07.01.2009 27.01.2009 27.01.2009 Неактивен 3342
Risperidone II-1936/16.04.2008 RISPOLEPT CONSTA 50 MG, Powder and solvent for prolonged release suspension for injection, 50, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 221.22 44.24 265.46 4% 8.85 230.07 46.01 276.08 16% 25 255.07 51.01 306.08 НСР-8512/16.03.2016; НСР-10674/21.10.2016; НСР-13237/17.07.2017 02.12.2016 02.11.2017 Заличен 3343
Risperidone II-1936/16.04.2008 RISPOLEPT CONSTA 50 MG, Powder and solvent for prolonged release suspension for injection, 50, mg, Pack: 1 Johnson & Johnson d.o.o., Словения Janssen Pharmaceutica N.V., Belgium 221.22 44.24 265.46 4% 8.85 230.07 46.01 276.08 16% 25 255.07 51.01 306.08 НСР-8512/16.03.2016; НСР-10674/21.10.2016 02.12.2016 02.12.2016 Неактивен 3343
Showing 12776 to 12801 of 17079 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте